年齢と血清状態によるCOVID-19ワクチンの優先順位付け戦略
Kate M Bubar1,2, Kyle Reinholt3, Stephen M Kissler4
1Department of Applied Mathematics, University of Colorado Boulder, Boulder, CO 80309, USA. kate.bubar@colorado.edu daniel.larremore@colorado.edu.
Science (New York, N.Y.)
|January 22, 2021
まとめ
重症急性呼吸器症候群のコロナウイルス2型 (SARS-CoV-2) ワクチンを20~49歳の成人に対して優先的に接種することで,感染を最小限に抑え,60歳以上の者に対して予防接種を行うことで死亡率と寿命の損失を減少させました. 前感染の検査により,ワクチンの効果と公平性が向上しました.
科学分野:
- 流行病学について
- 数学モデリング
- ワクチン学
背景:
- 重症急性呼吸器症候群コロナウイルス2型 (SARS-CoV-2型) ワクチンの初期供給量が限られているため,戦略的配分が必要である.
- 優先順位付け戦略は,疫病管理におけるワクチンプログラムの有効性に大きな影響を与えます.
研究 の 目的:
- SARS-CoV-2に対する5つの年齢層別ワクチン接種優先順位戦略の影響を比較する.
- ワクチンの配分を最適化し,不平等を減らすために,血清検査の役割を評価する.
主な方法:
- 異なる年齢層による予防接種優先順位設定シナリオをシミュレートするための数学的モデルの開発と適用
- 累積的な発生率,死亡率,失われた寿命年数に基づく戦略の比較
主要な成果:
- 20歳から49歳までの成人に優先的に投与された感染阻害ワクチンは,累積的な発生を最小限に抑えました.
- 60歳以上の個人に優先的にワクチンを接種することで,死亡率と失われる寿命はほとんどのシナリオで最小限に抑えられました.
- 個体レベルの血清検査は,血清陰性個人を特定するために,各ワクチン用量の影響を高め,不平等に対処しました.
結論:
- 最適なSARS-CoV-2ワクチンの優先順位戦略は,望ましい結果 (例えば,感染率と死亡率の減少) に依存する.
- 血清検査を組み込むことは,ワクチンの有効性を向上させ,健康上の格差を軽減することができます.
- モデリングの枠組みは,感染率や免疫レベルを含む様々な国別状況に適応できます.
関連する概念動画
01:26Pharmacokinetic Models: Comparison and Selection Criterion
218
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
218
01:51Vaccinations
49.3K
Overview
49.3K
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
71
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
71
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
99
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
99
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
85
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
85
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
95
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
95